Cargando…

New Challenges in the Diagnosis of Kidney Damage Due to Immune Checkpoint Inhibitors Therapy: An Observational Clinical Study

In recent years, immunotherapy has been postulated as one of the most effective strategies in the fight against cancer. The greatest success in this field has been achieved with the inhibition of molecules involved in slowing down the adaptive immune response by immune checkpoint inhibitors (ICIs)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Vicente-Vicente, Laura, Casanova, Alfredo G., Tascón, Javier, Prieto, Marta, Morales, Ana I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416935/ https://www.ncbi.nlm.nih.gov/pubmed/37568887 http://dx.doi.org/10.3390/diagnostics13152524

Ejemplares similares

Early Diagnosis of Kidney Damage Associated with Tobacco Use: Preventive Application
por: Tascón, Javier, et al.
Publicado: (2022)

Designing new diagnostic systems for the early detection of tobacco-associated chronic renal damage in patients of a primary care centre in Salamanca, Spain: an observational, prospective study protocol
por: Prieto, Marta, et al.
Publicado: (2020)

Are Antioxidants Useful in Preventing the Progression of Chronic Kidney Disease?
por: Casanova, Alfredo G., et al.
Publicado: (2021)

Diagnosis of Cardiac Surgery-Associated Acute Kidney Injury: State of the Art and Perspectives
por: Casanova, Alfredo G., et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management
por: Seethapathy, Harish, et al.
Publicado: (2021)

Protocol for mathematical prediction of patient response and survival to immune checkpoint inhibitor immunotherapy
por: Butner, Joseph D., et al.
Publicado: (2022)

Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study
por: Koks, Marije S., et al.
Publicado: (2021)

Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial
por: da Silva Lopes, André Manuel, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine
por: Longhitano, Elisa, et al.
Publicado: (2023)

Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors
por: Youssef, Alexey, et al.
Publicado: (2018)

Isolated Neutropenia Due to Immune Checkpoint Inhibitors
por: Jalil, Ahmad, et al.
Publicado: (2023)

Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer
por: Antill, Yoland, et al.
Publicado: (2021)

Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study
por: Nishikawa, Tatsuya, et al.
Publicado: (2022)

Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study
por: Delombaerde, Danielle, et al.
Publicado: (2023)

Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective study
por: Daoussis, Dimitrios, et al.
Publicado: (2020)

Albuminuria Pre-Emptively Identifies Cardiac Patients at Risk of Contrast-Induced Nephropathy
por: Vicente-Vicente, Laura, et al.
Publicado: (2021)

Bioanalytical Challenges due to Prior Checkpoint Inhibitor Exposure: Interference and Mitigation in Drug Concentration and Immunogenicity Assays
por: Dengler, Andrew F., et al.
Publicado: (2021)

Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab
por: McCormick, Benjamin Joseph, et al.
Publicado: (2023)

Immune checkpoint inhibitors in lymphoma: challenges and opportunities
por: Hatic, Haris, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge
por: Marmorino, Federica, et al.
Publicado: (2020)

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors
por: Stamatouli, Angeliki M., et al.
Publicado: (2018)

Thyroid Dysfunctions Due to Immune Checkpoint Inhibitors: A Review
por: El Sabbagh, Rawaa, et al.
Publicado: (2020)

The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicity
por: Moss, Emily M., et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
por: Liu, Xiufeng, et al.
Publicado: (2019)

Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge
por: Catalano, Martina, et al.
Publicado: (2022)

Progress and Challenges of Immune Checkpoint Inhibitor-Induced Hypophysitis
por: Chen, Piaohong, et al.
Publicado: (2023)

Isolation of human and murine hematopoietic stem cells for DNA damage and DNA repair assays
por: Rodríguez, Alfredo, et al.
Publicado: (2021)

Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?
por: Li, Yinuo, et al.
Publicado: (2023)

Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial
por: Ko, Mi Mi, et al.
Publicado: (2023)

An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial
por: Fraterman, Itske, et al.
Publicado: (2023)

SAT-491 Transient Thyrotoxicosis with Immune Checkpoint Inhibitors Therapy: The Importance of Endocrine Evaluation
por: Martins, Diana Cruz, et al.
Publicado: (2020)

Plasma Exchange in Patients With Myositis due to Immune Checkpoint Inhibitor Therapy
por: Katyal, Nakul, et al.
Publicado: (2023)

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
por: Kostine, Marie, et al.
Publicado: (2021)

A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry
por: Caliskan, Etem, et al.
Publicado: (2019)

Identification of Potential Biomarkers of Chronic Kidney Disease in Individuals with Diabetes: Protocol for a Cross-sectional Observational Study
por: Lecamwasam, Ashani R, et al.
Publicado: (2020)

Development of an Information Guideline for Kidney Transplant Recipients in a Clinical Trial: Protocol for a Modified Delphi Method
por: Faraldo-Cabana, Araceli, et al.
Publicado: (2023)

Nephrotoxicity of Immune Checkpoint Inhibitors: Acute Kidney Injury and Beyond
por: Tinawi, Mohammad, et al.
Publicado: (2020)

Acute kidney injury in patients treated with immune checkpoint inhibitors
por: Gupta, Shruti, et al.
Publicado: (2021)

Irreversible Kidney Damage due to Multicentric Castleman's Disease
por: Kahn, Fredrik, et al.
Publicado: (2008)

Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma
por: Sanders, Stephanie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g2bfsueohtjc56v82ike2i47qr